Evidence map›Paper›PMID 19372463›Full record

ArticleCirculation research2009

Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth.

Laura A DiMichele, Zeenat S Hakim, Rebecca L Sayers, Mauricio Rojas, Robert J Schwartz, Christopher P Mack, Joan M Taylor

Abstract read
In one paragraph

Article in Circulation research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Laura A DiMicheleDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Zeenat S Hakim
Rebecca L Sayers
Mauricio Rojas
Robert J Schwartz
Christopher P Mack
Joan M Taylor
Mahindra and Mahindra Limited (India) · IN

Funding

Regulation of Smooth Muscle Differentiation by RhoAR01HL070953 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MACK, CHRISTOPHER P. · 2002 to 2012
$2.8M
FAK Signaling in cardiac growth and hypertrophyR01HL081844 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2005 to 2013
$2.6M
Smooth muscle adhesion and plasticity in coronary and outflow tract developmentR01HL102446 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M · 2010 to 2013
$1.3M
Adhesion Signaling in Vascular Growth and DevelopmentR01HL071054 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, JOAN M. · 2003 to 2006
$1.2M
NHLBI NIH HHS HL070953NHLBI NIH HHS HL-071054NHLBI NIH HHS HL-081844NHLBI NIH HHS R01 HL070953NHLBI NIH HHS R01 HL071054NHLBI NIH HHS R01 HL081844NHLBI NIH HHS R01 HL102446
6 · The paper itself

Abstract

Focal adhesion kinase (FAK) is strongly activated by integrins and growth factors and is essential for embryonic development. We previously showed that the C terminus of FAK is expressed as a separate protein termed FAK-related nonkinase (FRNK) in a smooth muscle cell-selective fashion and that FRNK functions to buffer FAK-dependent signals. We now show that FRNK is also transiently expressed in the neonatal myocardium, with peak levels occurring 5 to 7 days postnatal, just before cell cycle withdrawal. Using novel mouse models, we demonstrate that cardiac-selective expression of FRNK (leading to inhibition of FAK) starting at embryonic day 10.5 leads to a severe ventricular noncompaction defect associated with reduced cardiomyocyte proliferation. Remarkably, postnatal expression of nearly identical levels of FRNK is well tolerated and does not affect viability or anabolic cardiac growth. Nonetheless, FRNK expression in the adult heart does attenuate pathological cardiac hypertrophy following aortic banding, confirming and extending our previous data that this compensatory response is blunted in FAK null hearts. Our mechanistic studies in cultured neonatal cardiomyocytes reveal that FRNK expression induces p38/p27(kip)-dependent cell cycle withdrawal and attenuates extracellular signal-regulated kinase-dependent hypertrophic growth. These findings indicate that dynamic expression of FRNK in the neonatal heart may function to promote cardiomyocyte quiescence in an environment that is particularly rich in growth factors and growth promoting extracellular matrices.

Indexed as

AnimalsCell CycleCell ProliferationCells, CulturedCyclin-Dependent Kinase Inhibitor p27FemaleFocal Adhesion Protein-Tyrosine KinasesHeartMiceMice, Inbred C57BLMice, TransgenicMyocytes, Cardiacp38 Mitogen-Activated Protein KinasesProtein-Tyrosine KinasesProto-Oncogene Proteins c-mycRatsCyclin-Dependent Kinase Inhibitor p27FAK-related nonkinaseFocal Adhesion Protein-Tyrosine KinasesMyc protein, mousep38 Mitogen-Activated Protein KinasesProtein-Tyrosine KinasesProto-Oncogene Proteins c-myc

Identifiers

PMID19372463
PMCPMC4535181
OpenAlexW2137540342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.